Search for Clinical Trial Results
Scleroderma, Systemic - 20 Studies Found
Status | Study |
Completed |
Study Name: Pulmonary Involvement in Scleroderma: A Clinical Study of the Safety and Efficacy of Mycophenolate Mofetil in Scleroderma Patients With Lung Involvement Condition: Scleroderma, Systemic Date: 2006-06-02 Interventions: Drug: Mycophenolate mofetil |
Completed |
Study Name: Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2006-07-03 Interventions: Drug: High-dose intravenous immunoglobulin (Venoglobulin-IH) |
Terminated |
Study Name: Thalidomide for Decreasing Collagen Biosynthesis in People With Progressive Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2007-01-03 Interventions:
|
Recruiting |
Study Name: A Trial to Compare Nintedanib With Placebo for Patients With Scleroderma Related Lung Fibrosis Condition: Scleroderma, Systemic Date: 2015-10-08 Interventions:
|
Completed |
Study Name: Imatinib in Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2007-07-24 Interventions: Drug: Imatinib mesylate 100 mg orally daily increased by 100 mg/day every 2 weeks to maximum of 400 mg d |
Not yet recruiting |
Study Name: Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2017-01-31 Interventions:
|
Recruiting |
Study Name: Role of Circulating Cytotoxic Lymphocytes in Endothelial Cell Injury in Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2015-12-09 Interventions: Other: blood samples one blood sample will be done for dos |
Active, not recruiting |
Study Name: Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2014-11-03 Interventions:
|
Not yet recruiting |
Study Name: The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2015-06-15 Interventions: Drug: bosentan 62.5 mg oral twice daily for 4 weeks, then 125 mg oral twice daily. |
Not yet recruiting |
Study Name: Platelet Gel in Systemic Sclerosis Condition: Scleroderma, Systemic Date: 2007-04-19 Interventions: Drug: Platelet Gel |